Call For Abstracts

Submissions Closed

Abstracts for publication in the RWCS conference app and virtual platform may be submitted. Abstracts should be a maximum of 250 words which does not include title, authors, etc. Encore presentations are accepted. Tables/graphs be included as long as all data fits on a single page. Among submitted abstracts, the top FOUR rated abstracts will be selected for display in the conference area.

Deadline to submit: January 10, 2024

AVOIDANCE OF COMMERCIALISM

Any exhibit, of which the cost is underwritten to any extent by a pharmaceutical company or other commercial enterprise, must avoid commercialism. Trade names must not be used for drugs, devices and/or instrumentation including lasers. In addition, such an exhibit should include a clear but inconspicuous acknowledgment stating that a portion of its cost was underwritten and identify the particular commercial company involved. No advertising matter of any kind may be distributed nor will any material display which, in any way, directly promotes the commercial interest of any particular company, enterprise, or the exhibitor be permitted. Any medications or other substances, devices or equipment referred to in exhibit materials must be identified by their scientific names.

Note: Sponsorship or funding by a commercial enterprise must be noted in the lower right hand corner of the exhibit. Failure to do so will result in the exhibit being taken down.

QUESTIONS?

Should you need further information, please contact:
Nicole Gomez, Meeting Manager, by email at nicole.gomez@r-w-c-s.com.

Questions?

Click HERE for questions or to request additional information regarding the 2024 RWCS Symposia.